期刊文献+

MDRD与CKD-EPI肾小球滤过率评估公式在外周动脉疾病患者中的应用 被引量:9

Application of MDRD and CKD- EPI equations in patients with peripheral arterial diseases
原文传递
导出
摘要 目的比较简化MDRD公式与慢性肾脏病学流行病学合作研究(CKD—EPI)公式在评估外周动脉疾病(peripheral arterial disease,PAD)患者肾小球滤过率(GFR)中的适用性。方法采用回顾性队列研究,选择2005年在上海市和北京市8家医院被确诊为PAD的841例患者作为研究对象,分别利用MDRD与CKD—EPI公式估算肾小球滤过率(eGFR),应用Spearman相关性检验、Bland-Altman曲线和Kappa检验比较两种方程估算GFR的相关性和一致性,并利用净重新分类指数(net re-classification improvement,NRI)比较2个公式对死亡风险的评估能力。结果eGFRMDRD高于eGFRCKD-EPI,均值差为4.33ml·min^-1·(1.73m^2)^-1,但两者评估eGFR值的相关性和一致性良好(Kappa值为0.749,r=0.991,P〈0.05)。以MDRD为标准,CKD-EPI公式改变了152例(18.1%)患者的分期,其中9例(1.1%)分期上调,143例(17.0%)分期下调。全因死亡NRI为0.059(P〈0.05),心血管死亡NRI为0.022(P〉0.05),提示CKD—EPI公式仅对全因死亡的风险评估能力优于MDRD。结论CKD-EPI公式在PAD患者中的应用并未显著优于MDRD公式。 Objective To compare the performance of newly developed Chronic Kidney Disease Epidemiology Collaboration (CKD- EPI) equation and Modification of Diet in Renal Disease (MDRD) equation in patients with peripheral arterial diseases (PAD). Methods A total of 841 patients with PAD were enrolled in this retrospective cohort study. Estimated glomerular filtration rate (eGFR), calculated by MDRD and CKD-EPI equation respectively, was analyzed by Spearman correlation analysis, Bland-Ahman method and Kappa test for the evaluation of correlation and consistency. Net re- classification improvement (NRI) was adopted to compare the death risk assessment between these two equations. Results Although the eGFR was 4.33 ml. min^-1. (1.73 m^2)^-1 higher with MDRD equation than with CKD- EPI equation, there were still significant correlation and fine consistency between eGFRMDRD and eGFRCKD-EPI (Kappa: 0.749, r=0.991, P〈 0.05). The CKD- EPI equation reclassified 9 (1.1%) patients upward to higher eGFR category and 143 (17.0%) patients downward to lower eGFR category. Besides, the performance of risk assessment for all-cause death was better with CKD- EPI equation than with MDRD equation (NRI=0.059, P 〈 0.05), which was not the case for cardiovascular death (NRI=0.022, P 〉 0.05). Conclusions There is no solid evidence suggesting that CKD- EPI equation performs better than MDRD equation.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2015年第10期755-759,共5页 Chinese Journal of Nephrology
基金 上海市卫生和计划生育委员会资助项目(201440312)
关键词 肾小球滤过率 外周血管疾病 MDRD评估公式 CKD-EPI评估公式 Glomerular filtration rate Peripheral vascular diseases MDRD equation CKD-EPI equation
  • 相关文献

参考文献12

  • 1Tonelli M, Wanner C; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. Lipid management in chronic kidney disease: synopsis of the kidney disease: Improving Global Outcomes 2013 clinical practice guideline[J]. Ann Intern Med, 2014, 160(3): 182.
  • 2Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline[J]. Ann Intern Med, 2013, 158(11): 825-830.
  • 3Duncan K, Aronow WS, Babu S. Prevalence of moderate or severe chronic kidney disease in patients with severe peripheral arterial disease versus mild or moderate peripheral arterial disease[J]. Med Sci Monit, 2010, 16(12): CR584- CR587.
  • 4Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int Suppl, 2013, 3(1): 1-150.
  • 5Pugliese G, Solini A, Bonora E, et al. The Chronic Kidney Disease Epidemiology Collaboration (CKD - EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes[J]. Atherosclerosis, 2011, 218(1): 194-199.
  • 6Shafi T, Matsushita K, Selvin E, et al. Comparing the association of GFR estimated by the CKD - EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III) [J]. BMC Nephrol, 2012, 13: 42.
  • 7Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate[J]. JAMA, 2012, 307(18): 1941-1951.
  • 8Rognant N, Lemoine S, Laville M, et al. Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients[J]. Diabetes Care, 2011, 34(6): 1320-1322.
  • 9Ohsawa M, Tanno K, Itai K, et al. Concordance of CKD stages in estimation by the CKD - EPI equation and estimation by the MDRD equation in the Japanese general population: the Iwate KENCO Study[I]. Int J Cardiel, 2013, 165(2): 377-379.
  • 10Abu-Assi E, Lear P, Cabanas-Grandfo P, et al. A comparison of the CKD-EPI, MDRD-4, and Cockcroft-Gault equations to assess renal function in predicting all- cause mortality in acute coronary syndrome patients[J]. Int J Cardiol, 2013, 167(5): 2325-2326.

同被引文献72

  • 1陶军.在有心血管危险因素的人群中要特别重视筛查外周动脉疾病——2011年欧洲心脏病学会外周动脉疾病指南解读[J].中国循环杂志,2012,27(S01):101-104. 被引量:3
  • 2刘成国,阮连生.浙江省舟山渔区外周动脉病患病率调查[J].中华老年医学杂志,2005,24(11):863-865. 被引量:12
  • 3Tanaka M, Oida E, Nomura K, et al. The Na +-excreting efficacy of indapamide in combination with furosemide in massive edema [ J ]. Clin Exp Nephrol, 2005, 9(2) : 122-126.
  • 4Loew D, Barkow D, Schuster O, et al. Pharmacokinetic and pharmacodynamic study of the combination of furosemide retard and triamterene[ J].Eur J Clin Pharmacol, 1984, 26(2) :191-195.
  • 5Reubi FC, Cottier PT. Effects of Reduced Glomerular Filtration Rate on Responsiveness to Chlorothiazide and Mercurial Diuretics [ J ]. Circulation, 1961,23(2) :200-210.
  • 6Dussol B, Moussi-Frances J, Morange S, et al. A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease [ J ]. J Clin Hypertens (Greenwich) , 2012.14( 1 ) :32-37.
  • 7Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure [ J ]. J Cardiovasc Pharmaeol, 1995,26 ( 3 ) : 394-400.
  • 8Knauf H, Cawello W, Schmidt G, et al. The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rate [ J ]. Eur J Clin Pharmacol, 1994, 46 ( 1 ) :9-13.
  • 9Dussol B, Moussi-Frances J, Morange S, et al. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension [ J ]. Nephrol Dial Transplant,2005,20 ( 2 ) : 349-353.
  • 10Dormans TP, Gerlag PG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure [ J ]. Eur Heart J, 1996, 17 (12) : 1867-1874.

引证文献9

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部